PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
17-Feb-2020 Castor provides free access to data capture platform to support non-profit COVID19 research projects Castor
17-Feb-2020 ReNeuron Group plc - Positive Phase 2a stroke clinical data published ReNeuron Group plc
17-Feb-2020 Vifor Pharma acquires Priority Review Voucher Vifor Pharma Group
17-Feb-2020 Analysis of RNA sequences and modifications by mass spectrometry published in Nature Communications STORM Therapeutics Ltd
17-Feb-2020 Investigational Subcutaneous Formulation of Vedolizumab Achieves Clinical Remission at Week 52 in Patients with Moderately to Severely Active Crohn’s Disease Takeda Pharmaceutical Company Limited
17-Feb-2020 Peritoneal Dialysis Market to Boom in Near Future by 2026 Industry Key Players Reports and Data
14-Feb-2020 Regeneron’s therapeutic candidate for rare cholesterol disease expected to face pricing pressure, says GlobalData GlobalData
14-Feb-2020 Corrected Press Release: XBiotech Announces Preliminary Results of Tender Offer XBiotech
14-Feb-2020 New Phase 3b Interim Data from STARDUST Study Show Two-Thirds of Patients with Moderately to Severely Active Crohn’s Disease Achieved Clinical Remission After Two Doses of STELARA® (ustekinumab) Janssen Pharmaceutical Companies of Johnson & Johnson
14-Feb-2020 Verona Pharma Announces Publication of Key Phase 2b COPD Data in Respiratory Research Verona Pharma
14-Feb-2020 New Insights on Mechlorethamine/Chlormethine gel presented at 4th World Congress of Cutaneous Lymphomas Helsinn Group
14-Feb-2020 Narcolepsy Drugs Market To Reach $5,360 Million By 2026 Trends Market Research
13-Feb-2020 Launch of innovative medical food provides a palatable new option for people diagnosed with rare metabolic disorder in the UK Galen
13-Feb-2020 BioNTech Announces Commencement of Public Offering of American Depositary Shares BioNTech
13-Feb-2020 RauCon Pharma Partnering Conferences Limit Attendance For More Value RauCon GmbH & Co
13-Feb-2020 Takeda Demonstrates Ongoing Commitment in Rare Hematology By Continuing to Gather Real-World Evidence and Advance Personalized Treatment Takeda Pharmaceutical Company
13-Feb-2020 Innovative – Compliant – Trusted: Copley marks a new decade with a major rebrand and a new product range. Copley Scientifi
13-Feb-2020 ‘Genetic rewiring’ drives cancer’s drug resistance The Institute of Cancer Research
13-Feb-2020 Abeona Therapeutics Announces Positive Interim Data from MPS III Gene Therapy Programs Presented at WORLDSymposium™ Abeona Therapeutics Inc.
13-Feb-2020 Sosei Heptares Operational HighlightsSosei Heptares Operational Highlights and Consolidated Results for the 12 Months ended 31 December 2019 and Consolidated Results for the 12 Months ended 31 December 2019 Sosei Heptares